Analyst consensus rating
Veracyte Analyst Rating: Buy
Direct answer
Veracyte's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $46.22.
Forecast evidence checked November 12, 2026.
Get free Veracyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $25.11
- Average price target
- $46.22
- High price target
- $70.00
- Low price target
- $30.00
- Low target gap
- +19.5%
- Target upside
- +84.1%
- High target gap
- +178.8%
- Target range width
- 159.3%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Veracyte?
Veracyte has a verified Buy consensus. The same dataset has an average price target of $46.22.
How far are Veracyte's low and high targets from the recorded price?
The low target implies +19.5%, while the high target implies +178.8%.
How many analysts are included in Veracyte's consensus?
The verified consensus includes 9 analysts.
How is Veracyte's target upside or downside calculated?
The average target of $46.22 is divided by the recorded price of $25.11, then one is subtracted to produce +84.1%. This does not guarantee a future return.
When was Veracyte's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.